A share price of Reneo Pharmaceuticals Inc [RPHM] is currently trading at $1.50, up 7.91%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RPHM shares have gain 6.38% over the last week, with a monthly amount drifted -5.06%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Reneo Pharmaceuticals Inc [NASDAQ: RPHM] stock has seen the most recent analyst activity on December 15, 2023, when Leerink Partners downgraded its rating to a Market Perform. Previously, Jefferies downgraded its rating to Hold on December 15, 2023. On December 15, 2023, downgrade downgraded it’s rating to Neutral and revised its price target to $1.50 on the stock. William Blair downgraded its rating to a Mkt Perform. Robert W. Baird downgraded its rating to a Neutral and reduced its price target to $3 on December 14, 2023. Piper Sandler downgraded its rating to Neutral for this stock on December 14, 2023, and downed its price target to $4. In a note dated December 14, 2023, Ladenburg Thalmann downgraded an Neutral rating on this stock.
Reneo Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $0.98 and $9.21. Reneo Pharmaceuticals Inc [NASDAQ: RPHM] shares were valued at $1.50 at the most recent close of the market.
Analyzing the RPHM fundamentals
Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -85.67%, Pretax Profit Margin comes in at -77.03%, and Net Profit Margin reading is -77.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.72, Equity is -0.63 and Total Capital is -0.81. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3767 points at the first support level, and at 1.2533 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5967, and for the 2nd resistance point, it is at 1.6933.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Reneo Pharmaceuticals Inc [NASDAQ:RPHM] is 57.86. Also, the Quick Ratio is 57.86, while the Cash Ratio stands at 26.68.
Transactions by insiders
Recent insider trading involved Leonard Braden Michael, 10% Owner, that happened on Sep 16 ’24 when 0.17 million shares were purchased. 10% Owner, Leonard Braden Michael completed a deal on Sep 13 ’24 to buy 0.15 million shares. Meanwhile, 10% Owner Leonard Braden Michael bought 36176.0 shares on Sep 12 ’24.
